Corvus Pharmaceuticals (CRVS) Amortizatization of Intangibles (2023 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly Amortizatization of Intangibles came in at $17000.0 in Q1 2026, down 94.16% year-on-year from $291000.0 in Q1 2025, and down 93.49% quarter-over-quarter from $261000.0 in Q4 2025.
Corvus Pharmaceuticals (CRVS) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $17000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 94.16% year-over-year to $17000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 16.39% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, up 17.88% from the prior year.
- Amortizatization of Intangibles fell to $17000.0 in Q1 2026 per CRVS's latest filing, from $261000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $524000.0 in Q3 2024 and bottomed at $17000.0 in Q1 2026.
- The 4-year median for Amortizatization of Intangibles is $258000.0 (2023), against an average of $261307.7.
- Across the five-year window, Amortizatization of Intangibles surged 113.88% in 2024 and tumbled 94.16% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $127000.0 in 2023, then soared by 90.55% to $242000.0 in 2024, then gained by 7.85% to $261000.0 in 2025, then tumbled by 93.49% to $17000.0 in 2026.
- Per Business Quant, the three latest CRVS Amortizatization of Intangibles figures stand at $17000.0 (Q1 2026), $261000.0 (Q4 2025), and $459000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Corvus Pharmaceuticals | 1.17 Bn | 934.14 Mn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 261,000.00 |
| Dec 31, 2025 | 261,000.00 |
| Sep 30, 2025 | 459,000.00 |
| Sep 30, 2025 | 459,000.00 |
| Jun 30, 2025 | 334,000.00 |
| Jun 30, 2025 | 334,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Dec 31, 2024 | 242,000.00 |
| Dec 31, 2024 | 242,000.00 |
| Sep 30, 2024 | 524,000.00 |
| Sep 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Jun 30, 2024 | 224,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Mar 31, 2024 | 151,000.00 |
| Dec 31, 2023 | 127,000.00 |
| Dec 31, 2023 | 127,000.00 |